Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v30-EN Version v15-FR
Language English French
Date Updated 2024-02-14 2022-11-17
Drug Identification Number 02238830 02238830
Brand name CLAVULIN 400 CLAVULIN 400
Common or Proper name amoxicillin / clavulanate potassium for oral suspension amoxicillin / clavulanate potassium for oral suspension
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients AMOXICILLIN CLAVULANIC ACID AMOXICILLIN CLAVULANIC ACID
Strength(s) 400MG 57MG 400MG 57MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 70ML 70ML
ATC code J01CR J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-09-05 2022-09-05
Estimated end date 2023-03-31 2022-11-30
Actual end date 2023-03-15
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Inventory on allocation to support demand. For emergency supply, contact GSK Customer Service 1-800-387-7374. Supply released November 11, 2022 with limited quantity. Inventory was allocated to support demand. For emergency supply, contact GSK Customer Service 1-800-387-7374.
Health Canada comments